Role of MiR-155 Signal Pathway in Regulating Podocyte Injury Induced by TGF-β1

Abstract

Background/Aims: Transforming growth factor beta 1 (TGF-β1) plays a critical role in the pathogenesis of glomerulosclerosis. The purpose of this study was to examine the effects of inhibition of miR-155 on podocyte injury induced by TGF-β1 and to determine further molecular mediators involved in the effects of miR-155. Methods: Conditionally immortalized podocytes were cultured in vitro and they were divided into four groups: control; TGF-β1 treatment; TGF-β1 with miR-155 knockdown [using antisense oligonucleotides against miR-155 (ASO-miR-155)] and TGF-β1 with negative control antisense oligonucleotides (ASO-NC). Real time RT-PCR and Western blot analysis were employed to determine the mRNA and protein expression of nephrin, desmin and caspase-9, respectively. Flow cytometry was used to examine the apoptotic rate of podocytes and DAPI fluorescent staining was used to determine apoptotic morphology. In addition, we examined the levels of miR-155, TGF-β1, nephrin, desmin and caspase-9 in glomerular tissues of nephropathy induced by intravenous injections of adriamycin in rats. Results: mRNA and protein expression of desmin and caspase-9 was increased in cultured TGF-β1-treated podocytes, whereas nephrin was decreased as compared with the control group. Importantly, miR-155 knockdown significantly attenuated upregulation of desmin and caspase-9, and alleviated impairment of nephrin induced by TGF-β1. Moreover, the number of apoptotic podocytes was increased after exposure to TGF-β1 and this was alleviated after miR-155 knockdown. Knocking down miR-155 also decreased an apoptosis rate of TGF-β1-treated podocytes. Note that negative control antisense oligonucleotides failed to alter an increase of the apoptosis rate in TGF-β1-treated podocytes. Consistent with in vitro results, expression of miR-155, TGF-β1, desmin and caspase-9 was increased and nephrin was decreased in glomerular tissues with nephropathy in vivo experiments. Conclusions: TGF-β1 impairs the protein expression of nephrin and amplifies the protein expression of desmin and caspase -9 via miR-155 signal pathway. Inhibition of miR-155 alleviates these changes in podocytes-treated with TGF-β1 and attenuated apoptosis of podocytes. Our data suggest that miR-155 plays a role in mediating TGF-β1-induced podocyte injury via nephrin, desmin and caspase-9. Results of the current study also indicate that blocking miR-155 signal has a protective effect on podocyte injury. Targeting one or more of these signaling molecules may present new opportunities for treatment and management of podocyte injury observed in glomerulosclerosis.

Functional Role of miR-155 in the Pathogenesis of Diabetes Mellitus and Its Complications

“…This view is supported by the augmented miR-155 expression observed in human GMCs in response to pro-inflammatory cytokines [ 161 ]. Moreover, treatment with LncRNA CTBP1-AS2 sponging miR-155 protects GMCs by diminishing miR-155-mediated repression of Foxo1 [ 47 ]; miR-155 inhibition was also able to reduce TGF-β1-induced signaling in podocytes in vitro , and a decreased expression of markers of podocyte injury was observed under miR-155 inhibition in vivo [ 162 , 163 ].…”

Autophagy Dysregulation in Diabetic Kidney Disease: From Pathophysiology to Pharmacological Interventions

“…Podocytes or glomerular epithelial cells constitute a critical component of the glomerular filtration barrier (GFB). As podocytes have no capacity to regenerate themselves, their loss, when significant, will subsequently result in an alteration of the GBF, leading to proteinuria and renal failure [ 63 , 64 , 65 , 66 ].…”

ATF4-dependent heme-oxygenase-1 attenuates diabetic nephropathy by inducing autophagy and inhibiting apoptosis in podocyte

“…Podocytes or glomerular epithelial cells are terminally specialized cells that play a critical role in forming the glomerular filtration barrier. Structural changes or injuries in podocytes are associated with renal injury resulting in proteinuria and severe renal insufficiency [3][4][5][6], and contributes to DN [7].…”